NLRP3 and dermatitis: AYZ inhibited the proliferation of mast cells, suppressed the activation of NLRP3 inflammasome and MAPKs/NF-kB signaling pathway, reduced the infiltration of inflammatory cells, and ameliorated DNCB-induced AD-like skin inflammation in mice.